Please login to the form below

Not currently logged in

NICE recommends Daiichi Sankyo's Lixiana for DVT and PE

Daiichi Sankyo logo

Institute's final guidance concludes the novel oral anticoagulant is cost effective

Novo Nordisk acquires two US biopharma companies

Novo Nordisk headquartersStrikes deals with Calibrium LLC and MB2

FDA follows WHO lead on biosimilar naming

FDA headquarters White OakProposes adding suffixes to distinguish biosimilar drug names

FDA clears Jardiance combo for type 2 diabetes

Lilly Boehringer diabetes collaborationCombination treatment Synjardy is fifth drug to come from Boehringer/Lilly diabetes alliance

Amgen wins FDA approval for cholesterol drug Repatha

Amgen Repatha evolocumabWill give it a quick launch in the US to catch-up with Sanofi's Praluent

Novo Nordisk plans $2bn expansion of its diabetes facilities

Comes as the Danish firm prepares to move oral semaglutide into phase III trials

Gilead and GSK pulmonary hypertension drugs work in tandem

GSK - logo on buildingLetairis and Adcirca combined shows clear therapeutic benefit

Pfizer starts Ibrance trials in early breast cancer

Pfizer headquartersHopes to encourage wider use of breakthrough drug

Lilly UK reappoints Hanover for public affairs account

Eli Lilly HQMed comms firm will also work with the pharma company on digital and corporate communications

Oncology directions

With increasingly expensive cancer drugs, what price should be paid for innovation?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Competition from within
Published in eyeforpharma July 29 by Rachel Howard...
Infographic: RA Perceptions
HCPs predict the future of the biologics market...
From chaos to calm: how to make sense of social media
What do you know about chaos theory?...